Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-13.37	26.39	30.46
Graham Fair Price	103.73	10.60	5.20
PEG	-92.87	0.06	-0.84
Price/Book	-2.34	1.24	1.26
Price/Cash Flow	278.89	42.84	11.31
Prices/Earnings	-75.51	18.39	75.12
Price/Sales	20.46	1.34	1.11
Price/FCF	278.89	42.84	11.31
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	18.84	0.22	0.19
Operating Margin	81.34	0.04	0.02
ROA	316.56	< 0.005	< 0.005
ROE	< 0.005	0.02	298.82
ROIC	< 0.005	0.01	302.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.47	-92.20
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.67	0.50	-25.72
EPS QOQ	-0.90	3.07	243.24
FCF QOQ	5.71	-0.74	-87.08
Revenue QOQ	0.14	-0.17	22.87
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	65.02	82.23	26.46
Days Sales Outstanding (DSO)	92.49	106.43	15.07
Inventory Turnover	1.38	1.09	-20.93
Debt/Capitalization	0.56	0.56	-0.12
Quick Ratio	0.88	0.84	-4.40
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.91	17.25	2.02
Cash	15.29	14.96	-2.20
Capex	-0.49	-0.47	5.04
Free Cash Flow	1.89	0.50	-73.71
Revenue	19.19	15.87	-17.30
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.18	1.17	-0.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.89	7.88	-0.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating